Defendant: Impax Laboratories Inc.
Date: Nov 25, 2010
Judge: No Information Provided
Patent infringement action. Defendant is seeking FDA approval to make and sell generic copies of plaintiff’s Simcor drug product before expiration of plaintiff’s U.S. Patent Nos. 6,080, 6,129,930, 6,406,715, 6,469,035, 6,676,967, 6,746,691, 6,818,229 and 7,011,848. Simcor is used to lower cholesterol and triglycerides in the blood.